This inventor holds 1 USPTO granted patent. Top assignee: Forschungszentrum Julich Gmbh. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Innovations of Joachim Vetter in Biomaterial Immobilization
Introduction
Joachim Vetter is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of biomaterials, particularly in the area of immobilization techniques. His work focuses on enhancing the interaction between biomaterials and surfaces, which is crucial for various applications in biotechnology and medicine.
Latest Patents
Joachim Vetter holds a patent for a method of biomaterial immobilization on an Si₃N₄ surface. This innovative technique involves covalent bonding of biomaterials, such as enzymes, cells, antigens, or antibodies, to a substrate with Si₃N₄ surfaces containing Si–NH₂ groups. The process utilizes a heterobifunctional cross-linking agent that reacts with the NH₂ groups of the surface and the biomaterial, ensuring effective immobilization. The Si₃N₄ surface can be created by precipitating a 10-1000 nm thick layer from a SiH₄/NH₃ mixture, followed by hydrolyzing cleaning to provide reactive NH₂ groups.
Career Highlights
Joachim Vetter is associated with Forschungszentrum Jülich GmbH, where he continues to advance research in biomaterials. His expertise and innovative approaches have positioned him as a key figure in his field. With a focus on practical applications, his work has the potential to impact various sectors, including healthcare and environmental science.
Collaborations
Joachim has collaborated with esteemed colleagues such as Marion Thust and Michael Josef Schoning. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in biomaterial applications.
Conclusion
Joachim Vetter's contributions to biomaterial immobilization represent a significant advancement in the field. His innovative techniques and collaborative efforts continue to pave the way for future developments in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
